Showing results (2001-2010 of 2,045) with videos related to

Sort By:
Pageof 205
Nature|May 28, 2025
Light-triggered regionally controlled n-doping of organic semiconductorsXin-Yi Wang, Yi-Fan Ding, Xiao-Yan Zhang, et al.
Vaccine|April 3, 2026
Immunogenicity and safety of a quadrivalent recombinant human papillomavirus vaccine (type 6/11/16/18) (Hansenula polymorpha): A randomized controlled phase 2 non-inferiority clinical trialSensen Yang, Defang Dai, Zhuang Kang, et al.
Nature Medicine|August 9, 2016
Low-dose interleukin-2 treatment selectively modulates CD4(+) T cell subsets in patients with systemic lupus erythematosusJing He, Xia Zhang, Yunbo Wei, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 4, 2021
Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 studyYoon-Koo Kang, Satoshi Morita, Taroh Satoh, et al.
Physical Review. E|February 7, 2025
Ionization dynamics and x-ray transmission of aluminum plasma at temperature reaching 110 eVQiang Yi, Fan Ye, Jian Lu, et al.
Chinese Medicine|October 17, 2025
Omics-based profiling and therapeutic potential of natural components in pan-Shennongjia medicinal herbsJun Song, Chong Yuan, Fei Wang, et al.
Molecular Cancer|November 22, 2025
Targeting SERPINB3-MAPK axis-mediated cuproptosis resistance enhances the response to antitumor immunotherapyXiao-Xiao Huang, Cheng-Ke Xie, Yi-Chao Mo, et al.
The Lancet. Oncology|September 30, 2021
Addition of ramucirumab or merestinib to standard first-line chemotherapy for locally advanced or metastatic biliary tract cancer: a randomised, double-blind, multicentre, phase 2 studyJuan W Valle, Arndt Vogel, Crystal S Denlinger, et al.
Nature|April 8, 2025
A Nd@C82-polymer interface for efficient and stable perovskite solar cellsYuexin Lin, Zhichao Lin, Shili Lv, et al.
Future Oncology (London, England)|September 25, 2023
Plain language summary of the TOPAZ-1 study: durvalumab and chemotherapy for advanced biliary tract cancerDo-Youn Oh, Aiwu Ruth He, Shukui Qin, et al.
Pageof 205